Skip to content
Georgia Commons
Menu

Senate · Introduced · 2025-2026 Regular Session

SR 851: Georgia Senate; creation of a life sciences caucus; encourage

Last action February 25, 2026 · Senate Read and Referred

A Georgia Senate resolution encourages senators to form a life sciences caucus, a bipartisan group meant to focus on biotechnology, pharmaceuticals, and related industries in the state.

Read the full resolution text

These buttons carry the resolution's own text, not the summaries below. Copy for LLM, View as markdown, and Send to AI use the Markdown version: the text as filed, then the summaries under a heading that names them as ours. View raw is the text alone.

The summaries below were written by an AI model (claude-sonnet-5) from the text of the resolution and are not part of it. Quote the text, not the summary. The stored text is the Introduced version, the latest the General Assembly's website lists.

In plain language

This resolution does not create a new law or spend state money. It is a formal statement from the Georgia Senate encouraging its members to set up a life sciences caucus, an informal group of senators who would meet to learn about and discuss the life sciences sector, which includes biotechnology, pharmaceuticals, medical devices, diagnostics, and agricultural biotechnology. The resolution explains why senators think this matters: Georgia has research universities, medical centers, and manufacturers tied to life sciences, and the sector supports jobs and public health. It says a caucus would give lawmakers a bipartisan forum to learn from industry leaders, academic institutions, and patient groups through briefings and site visits. The only binding instructions are procedural: the Senate resolves to encourage the caucus's creation, and it directs the Secretary of the Senate to distribute copies of the resolution to the public and press.

What the bill does

  • Formally encourages Georgia senators to establish a life sciences caucus within the Senate.
  • Describes the caucus as a bipartisan forum for legislators to learn about biotechnology, pharmaceuticals, medical devices, and agricultural biotechnology.
  • Directs the Secretary of the Senate to distribute copies of the resolution to the public and press.
  • Does not create any new agency, program, funding, or legal requirement; it only expresses the Senate's encouragement.

Who it affects

Georgia state senators, who would be encouraged to join or form the caucus, and by extension life sciences companies, research universities, academic medical centers, and workforce partners the caucus might engage with through briefings and site visits.

Why it matters

If senators act on this encouragement, it could lead to a standing group focused on life sciences policy, giving industry and academic stakeholders a more direct line to lawmakers. On its own, though, the resolution changes no law, funding, or rules.

Key provisions

  • The whereas clauses lay out the Senate's reasoning, citing the life sciences sector's role in Georgia's economy, workforce, and public health.
  • The resolving clause states the Senate encourages creation of a life sciences caucus in the Georgia Senate.
  • A further resolving clause directs the Secretary of the Senate to make copies available to the public and press.

From the bill

“NOW, THEREFORE, BE IT RESOLVED BY THE SENATE that the members of this body encourage the creation of a life sciences caucus in the Georgia Senate.”

This is the resolution's only operative action: encouraging senators to form the caucus.

Discussed in meetings (2)

The House and Senate meetings that took this bill up, from their machine transcripts. Each account was written by Georgia Commons with AI and is not part of the record; the video is what was said.

  1. Senate Rules Committee, March 30, 2026

    From 0:57:08 · Watch on the General Assembly's Vimeo channel

    Summary by Georgia Commons: A member asked whether SR 851, described as establishing a science caucus rather than a study committee, would advance automatically. The chair initially said it had not left Ethics, then clarified that it was not before Rules or on the general calendar. Another member said the committee had voted it out, and the chair said staff would look into it. No calendar placement was shown.

Status timeline

  1. 2026-02-25Senate Read and Referred (Senate)
  2. 2026-02-24Senate Hopper (Senate)

Sponsors

  • Chuck Hufstetler (R, SD-52)Primary sponsor
  • Ben Watson (R, SD-1)
  • Drew Echols (R, SD-49)
  • Shawn Still (R, SD-48)
  • Carden Summers (R, SD-13)
  • Kenya Wicks (D, SD-34)
  • Frank Ginn (R, SD-47)
  • Michael 'Doc' Rhett (D, SD-33)

Topics

  • life sciences
  • biotechnology
  • economic development
  • legislative caucus
  • healthcare policy

Ask about this bill

Answers come from this document. Not legal advice.

Machine-readable https://georgiacommons.org/bills/2025-2026/sr851.md · https://georgiacommons.org/bills/index.md · MCP https://mcp.georgiacommons.org/mcp

SR851: Georgia Senate; creation of a life sciences caucus; encourage | Georgia Commons